Drug Type Small molecule drug |
Synonyms BRI-1501 |
Target |
Action antagonists, inhibitors |
Mechanism H2 receptor antagonists(Histamine H2 receptor antagonists), cGMP-PDE inhibitors(3',5'-cyclic phosphodiesterase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC9H7Cl2N5 |
InChIKeyATCGGEJZONJOCL-UHFFFAOYSA-N |
CAS Registry57381-26-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Stomach Ulcer | Phase 1 | South Korea | 15 Apr 2016 |





